1. Home
  2. BWBBP vs KTTA Comparison

BWBBP vs KTTA Comparison

Compare BWBBP & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgewater Bancshares Inc.

BWBBP

Bridgewater Bancshares Inc.

HOLD

Current Price

$19.35

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$1.12

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWBBP
KTTA
Founded
N/A
2020
Country
United States
United States
Employees
325
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
5.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BWBBP
KTTA
Price
$19.35
$1.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
N/A
9.6M
Earning Date
N/A
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$0.28
52 Week High
N/A
$3.85

Technical Indicators

Market Signals
Indicator
BWBBP
KTTA
Relative Strength Index (RSI) 46.15 55.73
Support Level $19.00 $1.02
Resistance Level $19.58 $1.21
Average True Range (ATR) 0.28 0.09
MACD -0.02 -0.01
Stochastic Oscillator 44.03 33.62

Price Performance

Historical Comparison
BWBBP
KTTA

About BWBBP Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: